Its been found that gut microbiota dysbiosis (aka an imbalance with the healthy microorganisms that live in the gut affecting gut health) plays a factor in the GLP-1 resistance in individuals with Type 2 Diabetes
Serious side effects Less common but more serious side effects can include pancreatitis, gallbladder problems, kidney issues, and changes in vision for people with diabetes
Incorporation of a carboxylic acid moiety provided considerable GLP-1R potency gains with improved off-target pharmacology and reduced metabolic clearance, ultimately resulting in the identification of danuglipron
TB-500 cell migration and tissue regeneration pathways
The study examined around 60,000 people, including more than 10,000 people with both obesity and asthma taking GLP-1 drugs and around 50,000 matched controls
The results of the study revealed that those taking semaglutide were more sensitive to tastes than those taking a placebo